Viewing nowLipitor Tablet 20mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 201901774 · Approved 2019.03.25 · Insurance code 649604950
Improvement of hyperlipidemia; prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and patients with type 2 diabetes, lowering the risk of vascular intervention and angina as well. Furthermore, in patients with clinical evidence, it effectively reduces the risk of myocardial infarction, stroke, congestive heart failure hospitalization, and angina. This drug also treats hyperlipidemia by lowering total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, while increasing HDL cholesterol levels, thus improving lipid status in the blood. Additionally, it is effective in reducing cholesterol and associated lipid levels in certain patients with dyslipidemia that do not respond to diet and in pediatric patients with familial hypercholesterolemia. This medication promotes heart and vascular health and improves risk factors.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. It may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients who require greater reductions in LDL-cholesterol, treatment may be started at 20 mg or 40 mg once daily (only when a reduction in LDL-cholesterol of 45% or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to reduce LDL-cholesterol, use of LDL-cholesterol levels is recommended when initiating treatment and evaluating response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily, administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine above 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause muscle-related adverse effects. If you experience severe muscle pain or weakness, you should immediately stop use and consult a physician. In particular, if there is severe muscle pain accompanied by a significant increase in creatine kinase levels in blood tests, treatment should be halted. Patients with impaired liver function or liver disease should not use this medication, and regular liver function tests should be performed. Women who are pregnant or may become pregnant should not take this medication and must practice effective contraception during use. Nursing mothers should also not take this medication. Children under 10 years of age or patients with muscle disorders, and those taking certain medications (e.g., glecaprevir, pibrentasvir) should not use this medication. Elderly patients or those with decreased kidney function are at greater risk of muscle-related adverse effects and should be carefully monitored. There are many drug interactions, so dose adjustments or caution is necessary when taken with certain antibiotics, antifungals, antivirals, grapefruit juice, etc. If symptoms such as muscle pain, fatigue, or fever occur during treatment, inform your physician immediately and get tested. This medication contains lactose, so individuals with lactose intolerance should not take it. The medication should be stored out of reach of children and kept in its original container for safety. There are no specific antidotes for overdose, and treatment should be based on symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is also best to keep the medication at room temperature, between 1 to 30 degrees Celsius, avoiding very cold or very hot conditions.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.